ASP Isotopes (NASDAQ: ASPI) | Webinar Registration
RedChip Investor Webinar with ASP Isotopes (NASDAQ: ASPI)
Date & Time:
January 14, 2026 4:15 PM ET (US and Canada)
This exclusive event will provide investors with an opportunity to gain critical insights into ASP Isotopes' strategic initiatives and technological advancements. The webinar will reaffirmed the Company's confidence in its proprietary technology, robust leadership, and promising growth trajectory. ASP Isotopes will also highlight progress at its state-of-the-art isotope enrichment facilities in South Africa, where the commissioning of three key plants is underway. These include a Carbon-14 enrichment facility for healthcare and agrochemical applications, a Silicon-28 plant poised to revolutionize AI and quantum computing, and a Ytterbium-176 facility supporting cutting-edge radio-oncology therapies.
Speakers
Paul E. Mann
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
This webinar has concluded.
You can now register to watch the archived recording.
This exclusive event will provide investors with an opportunity to gain critical insights into ASP Isotopes' strategic initiatives and technological advancements. The webinar will reaffirmed the Company's confidence in its proprietary technology, robust leadership, and promising growth trajectory. ASP Isotopes will also highlight progress at its state-of-the-art isotope enrichment facilities in South Africa, where the commissioning of three key plants is underway. These include a Carbon-14 enrichment facility for healthcare and agrochemical applications, a Silicon-28 plant poised to revolutionize AI and quantum computing, and a Ytterbium-176 facility supporting cutting-edge radio-oncology therapies.
Speakers
Paul E. Mann
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
This exclusive event will provide investors with an opportunity to gain critical insights into ASP Isotopes' strategic initiatives and technological advancements. The webinar will reaffirmed the Company's confidence in its proprietary technology, robust leadership, and promising growth trajectory. ASP Isotopes will also highlight progress at its state-of-the-art isotope enrichment facilities in South Africa, where the commissioning of three key plants is underway. These include a Carbon-14 enrichment facility for healthcare and agrochemical applications, a Silicon-28 plant poised to revolutionize AI and quantum computing, and a Ytterbium-176 facility supporting cutting-edge radio-oncology therapies. 
